This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Qurient Co., Ltd.
Drug Names(s): Q701
Description: Q701 is a potent and selective TAM kinase-inhibitor being developed for cancer therapy. Q701 shows potent activity to inhibit metastasis and restore drug sensitivity of drug resistant tumor both in vitro and in vivo.
Additional information available to subscribers only: